ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.00
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
63,961.34
0.87%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Tonix Pharmaceuticals Holding Corporation (TNXP)

  7. Tonix Pharmaceuticals Holding Corporation (TNXP) 뉴스

TNXP Tonix Pharmaceuticals Holding Corporation

0.17
0.01005 (6.28%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Tonix Pharmaceuticals Holding Corporation TNXP 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.01005 6.28% 0.17 08:50:13
개장가 저가 고가 종가 전일 종가
0.16 0.1597 0.1703 0.1685 0.15995
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
24/04/202421:00GLOBETonix Pharmaceuticals Announces Presentation at Planet..
02/04/202405:15GLOBETonix Pharmaceuticals Reports Fourth Quarter and Full Year..
28/03/202422:32GLOBETonix Pharmaceuticals Announces Pricing of $4.4 Million..
25/03/202421:00GLOBETonix Pharmaceuticals Receives Rare Pediatric Disease..
21/03/202421:00GLOBETonix Pharmaceuticals Announces Poster Presentation..
20/03/202421:00GLOBETonix Pharmaceuticals Announces Selection of Two Contract..
19/03/202421:00GLOBETonix Pharmaceuticals Announces Transition to Fully..
12/03/202421:00GLOBETonix Pharmaceuticals Announces Presentation at BIO-Europe..
11/03/202421:05EDGAR2Form 8-K - Current report
11/03/202421:00GLOBETonix Pharmaceuticals Reports Improvement in “Brain Fog,” in..
07/03/202423:37GLOBENew to The Street Announces TV Episode 560 with its Five..
07/03/202422:06EDGAR2Form 8-K - Current report
07/03/202422:00GLOBETonix Pharmaceuticals Announces Publication in Psychiatry..
07/03/202407:01EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
06/03/202422:05EDGAR2Form 8-K - Current report
06/03/202422:00GLOBETonix Pharmaceuticals Selects EVERSANA® to Support Launch..
05/03/202422:05EDGAR2Form 8-K - Current report
05/03/202422:00GLOBETonix Pharmaceuticals Announces Translation of Preclinical..
01/03/202407:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202407:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202407:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202407:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202422:00GLOBETonix Pharmaceuticals Announces Presentation at The 6th..
28/02/202422:06EDGAR2Form 8-K - Current report
28/02/202422:00GLOBETonix Pharmaceuticals Completes Clinical Stage of Phase 1..
27/02/202422:07EDGAR2Form 8-K - Current report
27/02/202422:00GLOBETonix Pharmaceuticals Announces Positive Results from..
23/02/202423:30GLOBENew to The Street Announces Line-up of its Corporate..
20/02/202422:00GLOBETonix Pharmaceuticals to Participate in the 2024 BIO CEO &..
16/02/202423:30GLOBENew to The Street Airs Episode 556 Featuring Five Corporate..
16/02/202407:02EDGAR2Form 8-K - Current report
15/02/202405:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/02/202422:00GLOBETonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3..
13/02/202422:05EDGAR2Form 8-K - Current report
13/02/202422:00GLOBETonix Pharmaceuticals Announces Engagement of Rho as CRO to..
12/02/202422:00GLOBETonix Pharmaceuticals Announces FDA IND Clearance for DoD..
12/02/202421:06EDGAR2Form 8-K - Current report
31/01/202421:05EDGAR2Form 8-K - Current report
31/01/202421:00GLOBETonix Pharmaceuticals Announces Research Indicating..
29/01/202421:00EDGAR2Form 8-K - Current report
29/01/202421:00GLOBETonix Pharmaceuticals Announces Conditional Acceptance of..
26/01/202406:08EDGAR2Form 8-K - Current report
25/01/202421:00GLOBETonix Pharmaceuticals Announces KOL Webinar to Discuss..
20/01/202406:31EDGAR2Form 8-K - Current report
12/01/202406:53EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/01/202421:00GLOBETonix Pharmaceuticals Presents Additional Data Highlighting..
09/01/202407:07EDGAR2Form 8-K - Current report
09/01/202406:33EDGAR2Form DEF 14A - Other definitive proxy statements
04/01/202406:23EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/01/202421:00GLOBETonix Pharmaceuticals to Present at Two Upcoming Investor..

최근 히스토리

NASDAQ
TNXP
Tonix Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유